Highlights BioElectronics Corporation

Equities

BIEL

US09062H1086

Market Closed - OTC Markets Other stock markets 02:51:55 2024-07-12 pm EDT			5-day change	1st Jan Change
0.0002 ^USD	0.00%		+100.00%	0.00%

Mar. 25	BioElectronics Corporation Announces the Results and Publication of A Canine Arthritis Study	CI
Feb. 23	Bioelectronics Corporation Announces the Publication of Pilot Study Results	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

BioElectronics Corporation Announces the Results and Publication of A Canine Arthritis Study	Mar. 25	CI
Bioelectronics Corporation Announces the Publication of Pilot Study Results	Feb. 23	CI
BioElectronics Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-06	CI
BioElectronics Corporation Enters into a Distribution Agreement for RecoveryRx in Spain with Prim Group	22-04-06	CI
BioElectronics’ RecoveryRx Pain Relief Device Receives Clearance from Cofepris, Launching Distribution in Mexico	22-03-30	CI
BioElectronics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	22-02-15	CI
BioElectronics Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-18	CI
Bioelectronics Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-12	CI
BioElectronics Executes Distribution Agreement with KT Health, LLC for North American Retail Market	20-12-15	CI
BioElectronics' ActiPatch Therapy To Be Marketed By DonJoy Advantage	20-11-06	CI
Bioelectronics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2020	20-08-10	CI
BioElectronics Corporation Announces U.S. FDA Market Clearance for Over-The-Counter Treatment of Musculoskeletal Pain	20-02-03	CI
BioElectronics Files FDA 510(k) Application for Musculoskeletal Pain Complaints	19-08-20	CI
Bioelectronics Corporation Reports Earnings Results for the Full Year Ended December 31, 2018	19-08-01	CI
BioElectronics Corporation Announces FDA Market Clearance for Its Non-Opioid Postoperative Pain Therapy	19-07-01	CI
Bioelectronics Corporation Responds to FDA’s 510(K) Additional Information Requests for Musculoskeletal Pain Relief and Postoperative Pain Applications	19-04-23	CI
BioElectronics Corporation Announces Back Pain Clinical Study with Leading Australian Pain Center	19-03-08	CI
BioElectronics Files FDA Applications for Treatment of Musculoskeletal & Postoperative Pain	19-02-12	CI
Bioelectronics Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2018	18-11-28	CI
BioElectronics Corporation Announces Food & Drug Administration Market Clearance Update	18-11-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights BioElectronics Corporation

Equities

BIEL

US09062H1086

Highlights

Filters